222 related articles for article (PubMed ID: 34041016)
1. Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer.
Chen X; Lan H; He D; Wang Z; Xu R; Yuan J; Xiao M; Zhang Y; Gong L; Xiao S; Cao K
Front Oncol; 2021; 11():616133. PubMed ID: 34041016
[TBL] [Abstract][Full Text] [Related]
2. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
3. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
4. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
5. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer.
Liu J; Liu Y; Yang C; Liu J; Hao J
Transl Oncol; 2023 Nov; 37():101762. PubMed ID: 37619523
[TBL] [Abstract][Full Text] [Related]
7. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
9. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer.
Wang X; Li X; Wang X
J Cell Mol Med; 2021 Apr; 25(8):4053-4061. PubMed ID: 33675171
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer.
Li N; Li B; Zhan X
Front Genet; 2021; 12():616073. PubMed ID: 33679883
[TBL] [Abstract][Full Text] [Related]
11. Identification of NAD
Lin L; Chen L; Xie Z; Chen J; Li L; Lin A
Front Genet; 2022; 13():905238. PubMed ID: 35783253
[No Abstract] [Full Text] [Related]
12. Identification of glycosyltransferase-related genes signature and integrative analyses in patients with ovarian cancer.
Zhang Y; Zhou T; Tang Q; Feng B; Liang Y
Am J Clin Exp Immunol; 2024; 13(1):12-25. PubMed ID: 38496354
[TBL] [Abstract][Full Text] [Related]
13. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
Front Oncol; 2021; 11():711020. PubMed ID: 34621670
[TBL] [Abstract][Full Text] [Related]
14. Systematic profiling of diagnostic and prognostic value of autophagy-related genes for sarcoma patients.
Wang Y; Li J; Shao C; Tang X; Du Y; Xu T; Zhao Z; Hu H; Sheng Y; Hu C; Xi Y
BMC Cancer; 2021 Jan; 21(1):58. PubMed ID: 33435917
[TBL] [Abstract][Full Text] [Related]
15. Identification of CD8
Li L; Chen D; Luo X; Wang Z; Yu H; Gao W; Zhong W
Front Genet; 2022; 13():860161. PubMed ID: 35711935
[No Abstract] [Full Text] [Related]
16. Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma.
Xiao B; Liu L; Li A; Xiang C; Wang P; Li H; Xiao T
Front Oncol; 2020; 10():607622. PubMed ID: 33384961
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Inflammatory Response-Related Genes, and Prognosis and Immune Infiltration in Patients With Low-Grade Glioma.
Han T; Zuo Z; Qu M; Zhou Y; Li Q; Wang H
Front Pharmacol; 2021; 12():748993. PubMed ID: 34712139
[No Abstract] [Full Text] [Related]
18. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach.
Jia W; Li N; Wang J; Gong X; Ouedraogo SY; Wang Y; Zhao J; Grech G; Chen L; Zhan X
EPMA J; 2024 Jun; 15(2):375-404. PubMed ID: 38841623
[TBL] [Abstract][Full Text] [Related]
19. The Value of the Stemness Index in Ovarian Cancer Prognosis.
Yuan H; Yu Q; Pang J; Chen Y; Sheng M; Tang W
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741755
[TBL] [Abstract][Full Text] [Related]
20. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
